While Humana Inc has underperformed by -2.41%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, HUM rose by 12.57%, with highs and lows ranging from $315.35 to $206.87, whereas the simple moving average jumped by 8.68% in the last 200 days.
On October 14, 2025, Goldman started tracking Humana Inc (NYSE: HUM) recommending Sell. A report published by Evercore ISI on September 22, 2025, Initiated its previous ‘In-line’ rating for HUM. Raymond James also Upgraded HUM shares as ‘Outperform’, setting a target price of $315 on the company’s shares in a report dated May 01, 2025. BofA Securities November 06, 2024d the rating to Neutral on November 06, 2024, and set its price target from $247 to $308. KeyBanc Capital Markets initiated its ‘Sector Weight’ rating for HUM, as published in its report on October 11, 2024. Bernstein’s report from October 08, 2024 suggests a price prediction of $308 for HUM shares, giving the stock a ‘Outperform’ rating. TD Cowen also rated the stock as ‘Hold’.
Analysis of Humana Inc (HUM)
HUM currently pays a dividend of $3.54 per share, which means investors will get a return regardless of the company’s performance over the next few months. Further, the quarter-over-quarter increase in sales is 9.64%, showing a positive trend in the upcoming months.
In order to gain a clear picture of Humana Inc’s future performance, a variety of well-rounded analysis and research techniques can be applied, with equity being the most critical. The goal here is to ensure that your current return on equity of 9.03% is sufficient for you to turn a profit off your investment.
An average volume of 1.88M can be a very valuable indicator of volatility for HUM stock. On a monthly basis, the volatility of the stock is set at 4.15%, whereas on a weekly basis, it is put at 2.45%, with a loss of -1.95% over the past seven days. Furthermore, long-term investors anticipate a median target price of $291.92, showing growth from the present price of $285.61, which can serve as yet another indication of whether HUM is worth investing in or should be passed over.
How Do You Analyze Humana Inc Shares?
The USA based company Humana Inc (HUM) is one of the biggest names in Healthcare Plans. When comparing Humana Inc shares with other companies under Healthcare, the P/E value is an influential factor to note. This is because it represents an indication of the future growth of the company in terms of investors’ expectations. Ultimately, the value of the latter should demonstrate steady, rapid growth, which is an accurate measure of the company’s progress. In addition to the value of 21.92, there is a growth in quarterly earnings of -19.79%.
In addition to the fundamentals, you should also consider how many employees own shares in the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 0.24%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 95.89% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
